Instadose Pharma Corp.’s (OTC MKTS: INSD) Instadose Canada Is forming another international strategic joint venture agreement. This time it is with Sanctum Healthcare Remedies Private Limited, its India JV Partner. In turn, Sanctum agrees to grow, cultivate and sell Medicinal Cannabis and Cannabinoid Oil to Europe. It will market to Europe through INSD’s ‘Global Distribution Platform,’ INSD said yesterday.
The signing is the latest in a series of similar JV partnerships signed by INSD with international partners. Earlier this week it signed a JV Partnership Agreement with Columbia JV Partners. And now Egypt could be next.
On the latest Agreement news, Instadose Pharma Corp.’s (OTC MKTS: INSD) stock closed at $41.25 last evening, up 23.13%. Its volume was seven times its daily average: 23,071 yesterday vs a 3,320 average. The day prior it rose 24% — INSD stock is skyrocketing. In September it was $5 a share. Before its reverse merger on September 24, it was a shell company with no operations.
Grant Sanders, Chairman of Instadose, said, “Our partnership in India is a strategic pillar to Instadose’s Global Distribution Platform as Indian states such as Uttarakhand legalize Medical Cannabis.
“With a population of approximately 1.4 billion and a growing middle class, the potential for Medicinal Cannabis in India is substantial.”
Instadose may be eyeing a future JV partnership in the Middle East. As news broke about INSD’s JV Partnership in India, yesterday Instadose Tweeted this:
“Attending the Arab African Investment Forum discussing partnerships with Egypt.” David Curry is a VP at Instadose.
Grant Sanders, CEO of INSD, called its international relationships strategic. They are the bridge between growing/cultivation locations and selling markets. The Portuguese Republic, for instance, gives INSD access to the EU.
INSD is becoming a force in worldwide medicinal cannabis. From multiple growing and cultivation sites it is distributing to pharmaceutical firms globally. And it is negotiating for more.
Through Instadose, Pharma India Private Limited (IPD) was granted by the State of Uttarakhand during Q3 of 2021 initial approval to cultivate Medicinal Cannabis. The approval permits it to grow product on up to 500 acres of land.
Most recently, INSD entered international joint venture agreements with Portuguese Republic and Columbia, Mexico.
It sells its medicinal cannabis to a growing number of countries and markets through established entry points.
It established them in these locations:
- The Democratic Republic of the Congo (DRC)
- Republic of India
- Columbia, Mexico
- Republic of North Macedonia
- Portuguese Republic
It is competing in a large worldwide market. The global medicinal cannabis market is anticipated to reach $46.18 billion by 2026 at a CAGR of 22.9% from 2021, according to research by Market Data Forecast. It also distributes cannabinoid oil worldwide.
INSD through multiple entryways now touches five continents: Asia, North America, South America, Africa and now Europe.
Instadose Pharma Corp. (OTC MKTS: INSD) is seeking to create a large, outdoor growing, cultivation and global distribution program for its Medicinal Cannabis and Cannabinoid Oil. It would, through its Global Distribution Platform, gain global access to a new wholesale market worldwide.
This wholesale marketplace would then offer low-cost product as a bulk and active pharmaceutical ingredient. It would be large, sustainable, consistent, diverse and high quality.
INSD Chairman Grant Sanders said, “The commoditization of Cannabis will have a huge impact on countries where it can be grown outdoors, particularly in the developing world. The hope is that these countries will benefit from the development of a global market for Medicinal Cannabis.
INSD’s Global Distribution Platform is also focused on sustainable and long-term agreements. The goal is to give back to national people and the environment. Instadose aims to increase fresh water, jobs, education, food, quality of life and security.
INSD is focused on its three growing and cultivation centers in: Democratic Republic of the Congo (DRC), South Africa and Mexico.